Try our beta test site
23 studies found for:    "Klebsiella"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
Conditions: Anti-Biotic Resistance;   Klebsiella Pneumoniae
Interventions: Dietary Supplement: VSL#3;   Drug: Polyethylene glycol
2 Active, not recruiting Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
Conditions: Quinolone Resistance;   ESBL;   Klebsiella Species;   Infection
3 Completed Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
Conditions: Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: vancomycin-resistant enterococci and ESBL
4 Completed Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
Condition: Patients Colonized by Klebsiella Pneumoniae.
Interventions: Drug: Neomycin;   Drug: Streptomycin;   Drug: Gentamicins
5 Unknown  SDD for Eradicating CRKP Carriage
Condition: Carriers of Carbapenem-resistant Klebsiella Pneumonia
Intervention: Device: Gentamicin and polymyxin E
6 Completed Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
Conditions: Escherichia Coli Infections;   Klebsiella Pneumonia
7 Completed Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features
Condition: Necrotizing Fasciitis
8 Unknown  A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Condition: Patients Diagnosed With Concomitant KPC Associated Disease ,Bacteremia, Pneumonia.
Interventions: Drug: Colistin (Polymyxin E) 100mg x 4/d;   Drug: both medications;   Drug: will not receive PO treatment;   Drug: PO Garamycin 80mg x 4/d
9 Unknown  Antibiotics for Klebsiella Liver Abscess Study
Condition: Liver Abscess, Pyogenic
Interventions: Drug: Ciprofloxacin;   Drug: Ceftriaxone;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Ertapenem
10 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
11 Completed Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
Condition: Carriage of Carbapemen-resistant Klebsialle Pneumoniae
Intervention: Drug: Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.
12 Recruiting RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
Condition: Bloodstream Infections
Interventions: Drug: Meropenem;   Drug: Piperacillin-tazobactam combination product
13 Unknown  Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers
Condition: Bacterial Colonization
Interventions: Drug: Lactitol;   Drug: Lactobacillus
14 Completed Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Conditions: Infection;   E Coli Infections;   Klebsiella Infections;   Proteus Infections
15 Unknown  Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
Condition: Infections
Intervention: Drug: Colistin
16 Completed The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Condition: End-stage Renal Disease
Intervention: Other: renal replacement therapy
17 Recruiting Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Conditions: Anti-Infective Agents, Urinary;   Escherichia Coli Infections;   Klebsiella Infections;   Kidney Transplantation;   Urinary Tract Infections
Interventions: Drug: Sitafloxacin;   Drug: Ertapenem
18 Completed Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis
Condition: Community Acquired Infection
Intervention: Other: bacteremia caused by ESBL producing E.coli or K.pneumoniae
19 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline
20 Withdrawn Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers
Condition: Healthy
Interventions: Biological: QBKPN;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.